Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com.
Now here’s the best of what YOU had to say:
How to facilitate open innovation in the medical device space. “Peter von Dyck was frustrated. When trying to commercialize his latest medical device, it had simply become too inefficient to navigate through various sectors within the fractured medical device ecosystem. So what did Peter do? He created a system to solve this major dilema. In this interview with Peter von Dyck, we learn how e-Zassi is transforming the way medical device companies, innovators, researchers, and investors connect and collaborate in an effort to generate powerful new efficiencies in the development and commercialization of life-saving medical technologies.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
2012 JP Morgan Healthcare’s (wo)men’s club is changing in a good way. “he overall tone of this year’s JP Morgan Lollapalooza was cautiously upbeat, I would say. There are a few promising healthcare IPOs in the pipeline and a lot of opportunity presented by the changing healthcare field. Good companies are getting funded and bankers are busy again. Times are still tough but unemployment is slightly better. Healthcare IT is all the rage and there were even some whispers about early stage investing slowly climbing again. There was so much action around the conference headquarters at the St. Francis Hotel (also known as the worst conference venue on earth unless you love being crushed to death like you were at Altamont for a Rolling Stones concert) that security was even stronger than the airport in Fallujah.”
Medical device startups: Is crowdfunding in their future? “I’m not sure why it has not received more attention in the medical device start-up world, but the Entrepreneur Access to Capital Act (EACA), which recently passed in the U.S. House of Representatives, has the potential to open the door to intriguing fundraising possibilities for individual medical device innovators and start-ups.”
Chief Medical Information Officer’s role becoming more important. “Although I’ve been able to balance these three roles because of the extraordinary IS staff at BIDMC, good governance, and a supportive CEO, it’s challenging for one person to perform all these tasks. Many hospitals and health systems are expanding their management team to include a CMIO. Here are a few thoughts about the role of the CMIO.”
Ethics, disclosure and the FDA: Yaz, Yazmin just the beginning. “My reasoning, like the many consumer organizations which backed a total ban on using conflicted scientists, was that there are plenty of non-conflicted experts at American universities, research institutes or in private practice who are just as knowledgeable as people who sign consulting deals with industry. Moreover, eliminating the whiff of impropriety that appointing scientists with conflicts of interest brings would maintain the public’s faith in the integrityof the process, even if the appointee swears up and down thatis or she isn’t biased by the relationship.”
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Chris Seper runs MedCityNews.com and contributes regularly to the site. He is the vice president of healthcare for Breaking Media, MedCity's corporate owners. Reach him at [email protected].
